🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems

Recruitingn/aAges any - anyFemaleM.D. Anderson Cancer Center
NCT06373354 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To compare narrow-angle digital breast tomosynthesis (DBT) and wide-angle DBT.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women undergoing standard screening mammography. * Ability to understand and sign consent. Exclusion Criteria: * Pregnant women. * Women unable to consent. * Male patients.
💊

What it tests

  • Digital Breast Tomosynthesis (DBT)
📍

Where

1 site
MD Anderson Cancer Center
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy